Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract

Human Pathology

Volumn 41, Issue 11, 2010, Pages 1558-1565

  Riener, Marc Oliver ^a,b   Vogetseder, Alexander ^a   Pestalozzi, Bernhard C ^a   Clavien, Pierre Alain ^a   Probst Hensch, Nicole ^a   Kristiansen, Glen ^a   Jochum, Wolfram ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Institute of Pathology   (Switzerland)

Author keywords

Biliary dysplasia; CD24; Cholangiocarcinoma; Gallbladder carcinoma; P cadherin; p53

Indexed keywords

CD24 ANTIGEN; P CADHERIN; PROTEIN P53; BIOLOGICAL MARKER; CADHERIN; CD24 PROTEIN, HUMAN;

ADULT; ARTICLE; DYSPLASIA; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER CARCINOMA; HEPATOBILIARY SYSTEM; HEPATOBILIARY SYSTEM CANCER; HEPATOBILIARY SYSTEM INFLAMMATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLANGIOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY; AGED; BILE DUCT; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; GALLBLADDER NEOPLASMS; HEPATIC DUCT; INTRAHEPATIC BILE DUCT; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; BILE DUCT NEOPLASMS; BILE DUCTS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CADHERINS; CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; TISSUE ARRAY ANALYSIS;

EID: 77957968212     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.12.016     Document Type: Article

References (41)

1. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma Lancet 366 2005 1303 1314
2. Wistuba I.I., and Gazdar A.F. Gallbladder cancer: lessons from a rare tumour Nat Rev Cancer 4 2004 695 706
3. Li S.M., Yao S.K., Yamamura N., and Nakamura T. Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia World J Gastroenterol 9 2003 2579 2582
4. Chiba H., Nagai H., Ohdaira T., Yasuda Y., and Saito K. Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53 J Hepatobiliary Pancreat Surg 11 2004 409 416
5. Teh M., Wee A., and Raju G.C. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas Cancer 74 1994 1542 1545
6. Tsuneyama K., Sasaki M., Shimonishi T., and Nakanuma Y. Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions Pathol Int 54 2004 181 186
7. Harada K., Zen Y., and Kanemori Y. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions Hepatology 33 2001 1036 1042
8. Zhao H., Davydova L., Mandich D., Cartun R.W., and Ligato S. S100A4 protein and mesothelin expression in dysplasia and carcinoma of the extrahepatic bile duct Am J Clin Pathol 127 2007 374 379
9. Ligato S., Zhao H., Mandich D., and Cartun RW. KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies Diagn Cytopathol 36 2008 561 567
10. Riener M.O., Fritzsche F.R., and Clavien P.A. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas Hum Pathol 40 2009 1377 1383
11. Hansel D.E., Meeker A.K., and Hicks J. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma Mod Pathol 19 2006 772 779
12. Moreno Luna L.E., Kibb B., and Halling S.A. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures Gastroenterology 131 2006 1064 1072
13. Kipp B.R., Stadheim L.M., and Halling S.A. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures Am J Gastroenterol 99 2004 1675 1681
14. DeHaan R.D., Kipp B.R., and Smyrk T.C. An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas Hum Pathol 38 2007 491 499
15. Yagi T., and Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity Genes Dev 14 2000 1169 1180 (Pubitemid 30327498)
16. Shimoyama Y., Hirohashi S., and Hirano S. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas Cancer Res 49 1989 2128 2133
17. Han A.C., Edelson M.I., and Peralta Soler A. Cadherin expression in glandular tumors of the cervix Cancer 89 2000 2053 2058
18. Patel I.S., Madan P., Getsios S., Bertrand M.A., and MacCalman C.D. Cadherin switching in ovarian cancer progression Int J Cancer 106 2003 172 177
19. Lo Muzio L., Campisi G., and Farina A. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study BMC Cancer 5 2005 63
20. Palacios J., Benito N., and Pizarro A. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features Am J Pathol 146 1995 605 612
21. Paredes J., Albergaria A., and Oliveira J.T. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation Clin Cancer Res 11 2005 5869 5877
22. Kristiansen G., Sammar M., and Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule J Mol Histol 35 2004 255 262
23. Baumhoer D., Riener M.O., and Zlobec I. Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater Mod Pathol 22 2009 306 313
24. Christofori G. New signals from the invasive front Nature 441 2006 444 450
25. Hamilton S., and Aaltonen L. World Health Organization classification of tumours Pathology and Genetics of Tumours of the Digestive System 1st ed. 2000 IARC Press Lyon 157 217
26. Kononen J., Bubendorf L., and Kallioniemi A. Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
27. Obama K., Ura K., and Li M. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma Hepatology 41 2005 1339 1348
28. Su M.C., Hsu C., Kao H.L., and Jeng Y.M. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma Cancer Lett 235 2006 34 39
29. Agrawal S., Kuvshinoff B.W., and Khoury T. CD24 expression is an independent prognostic marker in cholangiocarcinoma J Gastrointest Surg 11 2007 445 451
30. Hardy R.G., Tselepis C., and Hoyland J. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon Gut 50 2002 513 519
31. Sagiv E., Memeo L., and Karin A. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis Gastroenterology 131 2006 630 639
32. Bircan S., Kapucuoglu N., Baspinar S., Inan G., and Candir O. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study Pathol Res Pract 202 2006 569 576
33. Kang Y.K., Kim W.H., and Jang J.J. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma Hum Pathol 33 2002 877 883
34. Weichert W., Denkert C., and Burkhardt M. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival Clin Cancer Res 11 2005 6574 6581
35. Kristiansen G., Denkert C., and Schluns K. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival Am J Pathol 161 2002 1215 1221
36. Kristiansen G., Pilarsky C., and Pervan J. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer Prostate 58 2004 183 192
37. Kristiansen G., Schluns K., and Yongwei Y. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients Br J Cancer 88 2003 231 236
38. Kristiansen G., Winzer K.J., and Mayordomo E. CD24 expression is a new prognostic marker in breast cancer Clin Cancer Res 9 2003 4906 4913
39. Sano A., Kato H., and Sakurai S. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma Ann Surg Oncol 16 2009 506 514
40. Lee H.J., Kim D.I., Kwak C., Ku J.H., and Moon K.C. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance Urology 72 2008 603 607
41. Chou Y.Y., Jeng Y.M., and Lee TT. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma Ann Surg Oncol 14 2007 2748 2758